Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cepan
- Development stage
- Unknown
- Lead developer
- UNIA Pharmaceutical Plant
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Cepan is a topical dermatological cream developed and manufactured by UNIA Pharmaceutical Plant. It is a multi-ingredient formulation containing onion ethanol extract (*Allii cepae extractum fluidum*), chamomile extract (*Chamomillae extractum*), sodium heparin (*Heparinum natricum*), and allantoin (*Allantoinum*). The product is specifically indicated for the prevention and treatment of various types of scars, including hypertrophic scars, keloids, and scars resulting from burns, surgery, or acne. Cepan works by softening and flattening scar tissue, improving skin elasticity, and reducing local inflammatory reactions. The botanical components provide anti-inflammatory and antimicrobial properties, while heparin acts to inhibit fibroblast proliferation and allantoin promotes tissue regeneration and soothing of the skin.
- Brand names
- Cepan
- Other names
- Cepan Cream
02
Targets
ATIII (Antithrombin III)
Beyond the preview
Go deeper on Cepan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cepan.